| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Not Another Meeting |
|
Advice You - Not Another Meeting
Recently, an Associated Press article reported on a study suggesting that company
staff meetings may "rank among the most inefficient exercises we perform." The
study, conducted for GroupSystems Corp., included 130 responses from workers in
organizations ranging from Int According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product el to the U.S. Navy to George Washington University. If you attend regular staff meetings at work, you might not be surprised that most respondents in this study found these meetings to often be too long, too poorly organized, and too unproductive, rarely resulting in imp ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in emented action items. Many of us attend a lot of meetings. In fact, approximately 11 million meetings occur in the U.S. each day, and most managers attend about 60 meetings each month. That’s a lot of meetings, especially if many of them are not very valuable. A meeting lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. for the purposes of this article — occurs anytime two or more people
come together for a scheduled interaction and a specific (if not stated) purpose.
Here are some of the common types of meetings: One-on-one meetings: You probably conduct or participate in one-on-one m here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe eetings with your manager
and/or your direct reports (in performance reviews, coaching sessions, career
development discussions, and so on). These meetings allow for private and
confidential discussions and allow you and the other person to build familiarity.
These mee d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ings can be challenging if you are poorly prepared. Small-group meetings: Managers frequently attend these types of meetings, and most staff meetings are attended by a small group of "staffers." Three to 15 or 20 participants come together to share new information, solve ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc problems, review project status, recognize
and celebrate accomplishments, train new skills, and so on. A common complaint is
that these meetings are poorly run and unproductive, as I've mentioned. Large-group meetings: You sometimes get together with 20 or more people, i easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi n a training class, department
meetings, recognition gatherings, and so on. These meetings typically involve the
least amount of two-way interaction between the meeting leader and participants.
Nonetheless, they need to be led effectively like any other meeting. Virtual nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically meetings (teleconference, videoconference, or Web conference): Phone, video, and/or the Web sometimes connect all or some meeting participants. Participants are "in the room" but physically separated by sometimes thousands of miles. This distance can increase the challeng and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ s of running an efficient and
productive meeting. To Meet or Not to Meet Below, we have listed types of information commonly delivered at work. Ask yourself whether these require a ‘Meeting’ or ‘No Meeting’ (in which another method of delivery, if available, may be mor ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi effective). Announce a small procedure change. • (No Meeting – Meetings are less effective when one-way information is shared. Typically, announcements are one-way and can be delivered by e-mail, bulletin board, etc. This might change if the announcement is likely to ra ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ise questions or
require persuasion or dialogue.) Brainstorm the solution of a problem. • (Meeting – Meetings are more effective when two-way dialogue is needed. Typically, meetings are a great way to generate ideas and solve problems. People have diverse perspectives dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod nd experiences that often spark creative solutions. These
meetings might be more effective if you inform participants of the problem
beforehand so they can bring ideas.) Review the progress of a team project. • (Meeting – Meetings are more effective when a close familiar cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ty and working
relationship needs to be built between team members. Project teams often need
face-to-face communication to discuss barriers, accomplishments, and adjust
plans.) Provide negative performance feedback to a direct report. • (Meeting – Meetings are more eff tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ective when you need to discuss sensitive
information with someone. We often make the mistake of avoiding face-to-face
encounters when delivering negative information or dealing with conflict. These
meetings should be two-way dialogues conducted in private.) Have severa t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel people review and respond to a proposal you’ve written. • (No Meeting – Meetings are less effective when reviewing written materials, such as reports or proposals, unless you want to bring people together to discuss feedback once it has all been gathered and assessed.) ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust et a direct report’s performance goals. • (Meeting – Meetings are more effective when managers need to include direct reports in decision making and a development plan. Managers often make the mistake of not involving direct reports in the goal-setting process. Managers s y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products hould
meet one-on-one with direct reports when they want to reinforce buy-in and
commitment.) Meetings are most effective when used to share two-way information, make decisions, and strengthen relationships: 1. Share two-way information — You might meet with other peop . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e to instruct,
advise, update, and persuade. 2. Make decisions — You might meet with other people to come to consensus, weigh options, generate ideas, resolve issues, create plans, and assign roles. 3. Strengthen relationships — You might meet with other people to get to elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip know one
another, build trust, create understanding, and promote a sense of belonging. Although regular staff meetings can have value, meeting for the sake of meeting is seldom a good use of time, and if a meeting is needed, make sure it is well organized and productive tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Failures In Customer Service Will Mean The Death Of Your Business How 'Hiring Now' Is A Hint You Have Problems
|